Forty original sequences of peptide substrates and inhibitors of protein kinases and phosphatases were aligned in a chain matrix without artificial gaps. Fifteen protein kinase peptide substrates and inhibitors (PKSI peptides) contained a common dipeptide ArgArg and also additional important tetra-, tri- and dipeptide homologies. Three further peptide substrates were significantly similar to these peptides but lacked the ArgArg dipeptide. Sequence comparison of individual PKSI peptides revealed probabilistically restricted consensus sequence--PKSI motif--comprising 8 homologous and 13 non-randomly distributed amino acids without considering mutation analysis. This template motif was compared with the consensus sequences of 12 different immunoglobulin domains. In 11 of 12 these domains, the starts of homologous segments were found at nearly the same domain related sites, beginning with serine. A single-triplet mutation of any of the first two triplet bases that encode equally localized amino acids in each of the two sequence sets (PKSI and Ig) revealed additional homologies with the other set. A primary derived motif version composed of 9 homologous and seven non-randomly distributed amino acids was consequently established by its feedback projection into the original sequence sets. This procedure yielded a second preliminary motif version (revised motif) formed by a sequence of 9 homologous amino acids and two non-randomly distributed amino acids. In addition, three shorter oligopeptide motifs called important stereotypes were derived, based on repeated homology between Ig chains and the revised motif. The most extensive similarities in terms of these stereotypes occurred in the CH2 and CH4 domains of Ig peptides, and inhibitors of cAMP dependent protein kinase and protein kinase A. Further comparisons based on a reference sequence set arranged with the aid of feedback projection revealed a lower similarity between variable Ig chains reflected in a decreased number of homologous amino acids. Two final motif versions, FMC and FMV, were found in two different subsets of constant and variable Ig chains, respectively. FMC was composed of seven homologous and one non-randomly distributed amino acids forming the dispersed structure STLR(C)LVSD, whereas 6 homologous and one questionable amino acid constituted FMV. Only CH4 and CH1 domain segments contained all five high-incidence amino acids, which represented a higher level of similarity than homologous amino acids of all preliminary and final motifs. Four such amino acids were present also in three PKSI peptides. All similarities described here occur in domain segments positionally overlapping with the CDR1 region of variable chains. The results are discussed in terms of immunoglobulin evolution, the position of Fc receptor binding sites and degeneration or mutability of the triplets of motif-constituting amino acids.

Center of Occupational Diseases National Institute of Public Health 100 42 Prague Czechia

See more in PubMed

Proc Natl Acad Sci U S A. 1981 Oct;78(10):6168-72 PubMed

Immunogenetics. 1994;40(4):306-8 PubMed

Immunol Rev. 1998 Apr;162:13-24 PubMed

Gene. 1999 Sep 30;238(1):179-93 PubMed

Immunol Rev. 1998 Apr;162:161-71 PubMed

J Mol Evol. 1995 Oct;41(4):421-9 PubMed

Eur J Immunol. 1987 Mar;17(3):437-40 PubMed

Ann Med. 1993 Aug;25(4):335-42 PubMed

Int Immunol. 1999 May;11(5):825-33 PubMed

Biochim Biophys Acta. 1996 Jun 7;1287(2-3):121-49 PubMed

Immunol Rev. 1998 Apr;162:143-51 PubMed

Crit Rev Biotechnol. 1997;17(2):123-47 PubMed

J Biol Chem. 1988 Mar 5;263(7):3402-10 PubMed

J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):475-94 PubMed

Int Immunol. 1996 Jun;8(6):847-54 PubMed

Mol Immunol. 1982 Oct;19(10):1245-54 PubMed

Proc Natl Acad Sci U S A. 1981 Jan;78(1):504-8 PubMed

J Protein Chem. 1997 Oct;16(7):713-20 PubMed

Mol Immunol. 1992 May;29(5):633-9 PubMed

Proc Natl Acad Sci U S A. 1981 Dec;78(12):7684-8 PubMed

J Mol Biol. 2000 Jan 21;295(3):613-25 PubMed

Anal Biochem. 1988 Dec;175(2):552-61 PubMed

Immunogenetics. 1995;42(3):159-71 PubMed

Comput Appl Biosci. 1993 Apr;9(2):205-9 PubMed

Mol Immunol. 1986 Dec;23(12):1365-72 PubMed

Proc Natl Acad Sci U S A. 1982 Mar;79(6):1999-2002 PubMed

Immunol Rev. 1998 Jun;163:59-76 PubMed

Bioinformatics. 1998;14(2):164-73 PubMed

Nature. 1988 Sep 1;335(6185):82-5 PubMed

J Biol Chem. 1987 Jan 15;262(2):772-7 PubMed

Nucleic Acids Res. 1982 Jul 10;10(13):4071-9 PubMed

J Mol Biol. 1996 Aug 2;260(5):664-77 PubMed

Mol Cell Biol. 1998 May;18(5):2571-85 PubMed

J Theor Biol. 1998 Aug 7;193(3):429-44 PubMed

Ancient phylogenetic beginnings of immunoglobulin hypermutation

Sequence similarities of protein kinase substrates and inhibitors with immunoglobulins and model immunoglobulin homologue: cell adhesion molecule from the living fossil sponge Geodia cydonium. Mapping of coherent database similarities and implications for evolution of CDR1 and hypermutation